← Open Payments lookup

KERRI WHITTINGTON: Open Payments

NPI 1275007510 · STARKVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$844 in 38 payments from 11 companies in 2025. Trend: 2023 $864 · 2024 $1,076 · 2025 $844

Food & beverage: $844
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$329
ABBVIE INC.10$175
Vanda Pharmaceuticals Inc.5$102
Otsuka America Pharmaceutical, Inc.2$52
Supernus Pharmaceuticals, Inc.2$44
Axsome Therapeutics, Inc.2$37
Janssen Pharmaceuticals, Inc2$33
Corium, LLC1$22
Collegium Pharmaceutical, Inc.1$18
Otsuka Pharmaceutical Development & Commercialization, Inc.1$17

Products named: CAPLYTA, VRAYLAR, FANAPT, REXULTI, Qelbree, Auvelity, SPRAVATO, Azstarys.

Industry payments across MS — which companies pay providers there.